Roberto Giugliani

National Institute on Population Medical Genetics

Papers

1

Total Citations

36

H-Index

1

About

Dr. Roberto Giugliani is a pioneering figure in the field of inborn errors of metabolism, with a particular focus on lysosomal storage disorders such as mucopolysaccharidoses (MPS). His research has significantly advanced the diagnosis, monitoring, and treatment of these rare genetic conditions. Among his most notable contributions is the development of a novel, high-throughput mass spectrometry assay for heparan sulfate, a key biomarker for MPS, which has been cited 36 times and represents a critical tool for both newborn screening and therapeutic monitoring. Dr. Giugliani’s work has directly improved patient outcomes by enabling earlier detection and more precise management of these devastating diseases. With a career spanning decades, he has authored hundreds of publications and has been instrumental in establishing international guidelines for MPS care. His impact is reflected in the widespread adoption of his diagnostic methods and his leadership in clinical trials for enzyme replacement therapies. For students and researchers, Dr. Giugliani exemplifies how translational research can bridge laboratory innovation and clinical practice, offering hope to families affected by rare metabolic disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
36
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses
36 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: National Institute on Population Medical Genetics

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago